Biodesix Quote - BDSX

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

0.2745

Bid

0.2626

Offer

0.274

Volume

1,356,865

0.2602 Day's Range 0.2866

0.1718 52 Week Range 2.04

Market Cap

40.232M

Previous Close

0.2762

Open

0.2762

Last Trade

0.274

Last Trade Time

Financial Volume

US$ 369,894

VWAP

0.272609

Average Volume (3m)

9,399,346

Shares Outstanding

146,563,031

Dividend Yield

PE Ratio

-0.89

Earnings Per Share (EPS)

-0.29

Revenue

71.32M

Net Profit

-42.93M

Biodesix Inc is a data-driven diagnostic solutions company. Its artificial intelligence-based platform helps to discover, develop, and commercialize solutions for clinical unmet needs, with a focus on lung disease. It provides biopharmaceutical companies with services that include diagnostic researc... Biodesix Inc is a data-driven diagnostic solutions company. Its artificial intelligence-based platform helps to discover, develop, and commercialize solutions for clinical unmet needs, with a focus on lung disease. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics. Show more

Sector

Medical Laboratories

Industry

Medical Laboratories

Website

www.biodesix.com

Headquarters

Wilmington, Delaware, USA

Founded

Biodesix Inc is listed in the Medical Laboratories sector of the NASDAQ with ticker BDSX. The last closing price for Biodesix was US$0.28. Over the last year, Biodesix shares have traded in a share price range of US$ 0.1718 to US$ 2.04.

Biodesix currently has 146,563,031 shares in issue. The market capitalisation of Biodesix is US$40.48 million. Biodesix has a price to earnings ratio (PE ratio) of -0.89.

Biodesix Partners with Association of Pulmonary Advanced Practice Providers (APAPP) to Deliver Nation’s First Medical Education for APPs on Biomarkers in Lung Nodule and Lung Cancer Programs

LOUISVILLE, Colo., June 10, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.0238	-7.97854508884	0.2983	0.3	0.262	1159809	0.28306078	CS
4	-0.0895	-24.5879120879	0.364	0.36985	0.262	2398916	0.31731631	CS
12	-0.4455	-61.875	0.72	0.775399	0.1718	9399346	0.36709426	CS
26	-1.0655	-79.5149253731	1.34	1.61	0.1718	4644633	0.39562317	CS
52	-1.3455	-83.0555555556	1.62	2.04	0.1718	2400090	0.4585716	CS
156	-1.2555	-82.0588235294	1.53	3	0.1718	879188	0.57070675	CS
260	-13.3155	-97.9801324503	13.59	31.99	0.1718	639524	1.35916112	CS

BDSX - Frequently Asked Questions (FAQ)

What is the current Biodesix share price?

The current share price of Biodesix is US$ 0.2745

How many Biodesix shares are in issue?

Biodesix has 146,563,031 shares in issue

What is the market cap of Biodesix?

The market capitalisation of Biodesix is USD 40.48M

What is the 1 year trading range for Biodesix share price?

Biodesix has traded in the range of US$ 0.1718 to US$ 2.04 during the past year

What is the PE ratio of Biodesix?

The price to earnings ratio of Biodesix is -0.89

What is the cash to sales ratio of Biodesix?

The cash to sales ratio of Biodesix is 0.53

What is the reporting currency for Biodesix?

Biodesix reports financial results in USD

What is the latest annual turnover for Biodesix?

The latest annual turnover of Biodesix is USD 71.32M

What is the latest annual profit for Biodesix?

The latest annual profit of Biodesix is USD -42.93M

What is the registered address of Biodesix?

The registered address for Biodesix is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Biodesix website address?

The website address for Biodesix is www.biodesix.com

Which industry sector does Biodesix operate in?

Biodesix operates in the MEDICAL LABORATORIES sector

Symbol	Price	Vol.
NXTTNext Technology Holding Inc	US$ 3.44 (158.65%)	13.84M
WHLRWheeler Real Estate Investment Trust Inc	US$ 7.15 (109.06%)	52.35M
CTORCitius Oncology Inc	US$ 2.63 (69.68%)	20.77M
LUCYInnovative Eyewear Inc	US$ 3.52 (54.39%)	111.21M
LGCLLucas GC Ltd	US$ 1.0407 (53.16%)	11.17M
NWGLNature Wood Group Ltd	US$ 1.71 (-69.63%)	3.99M
ICUSeaStar Medical Holding Corporation	US$ 0.351 (-64.05%)	21.9M
MBRXMoleculin Biotech Inc	US$ 0.259999 (-55.40%)	16.84M
RGCRegencell Bioscience Holdings Ltd	US$ 37.50 (-40.81%)	2.22M
CGTLCreative Global Technology Holdings Ltd	US$ 1.4399 (-36.57%)	6.71M
HCTIHealthcare Triangle Inc	US$ 0.0297 (12.08%)	583.72M
DFLIDragonfly Energy Holdings Corporation	US$ 0.245 (12.39%)	334.37M
GNLNGreenlane Holdings Inc	US$ 0.009 (-13.04%)	262.88M
NVDANVIDIA Corporation	US$ 143.85 (-1.12%)	242.95M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 12.359 (-0.09%)	193.97M

Symbol

Price

Vol.

HCTIHealthcare Triangle Inc

US$ 0.0297

(12.08%)

583.72M

DFLIDragonfly Energy Holdings Corporation

US$ 0.245

(12.39%)

334.37M

GNLNGreenlane Holdings Inc

US$ 0.009

(-13.04%)

262.88M

NVDANVIDIA Corporation

US$ 143.85

(-1.12%)

242.95M

TSLLDirexion Daily TSLA Bull 2X Trust ETF

US$ 12.359

(-0.09%)

193.97M

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Biodesix Inc (BDSX) Share Price

Biodesix Inc (BDSX)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

About Biodesix Inc

Ask ADVFN Intelligence (AI)

BDSX Latest News

Biodesix Partners with Association of Pulmonary Advanced Practice Providers (APAPP) to Deliver Nation’s First Medical Education for APPs on Biomarkers in Lung Nodule and Lung Cancer Programs

Form S-8 - Securities to be offered to employees in employee benefit plans

Biodesix Announces New Data on the VeriStrat® Test to be Presented at the 2025 ASCO Annual Meeting

Biodesix to Participate in Upcoming Investor Conferences

Biodesix Announces New Clinical and Economic Data for its Nodify Lung® Tests at ISPOR and ATS

Denver Post Names Biodesix a Winner of Top Workplaces 2025 Award

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Biodesix Partners with Association of Pulmonary Advanced Practice Providers (APAPP) to Deliver Nation’s First Medical Education for APPs on Biomarkers in Lung Nodule and Lung Cancer Programs

Form S-8 - Securities to be offered to employees in employee benefit plans

Biodesix Announces New Data on the VeriStrat® Test to be Presented at the 2025 ASCO Annual Meeting

Biodesix to Participate in Upcoming Investor Conferences

Biodesix Announces New Clinical and Economic Data for its Nodify Lung® Tests at ISPOR and ATS

Denver Post Names Biodesix a Winner of Top Workplaces 2025 Award

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

BDSX - Frequently Asked Questions (FAQ)

Movers

BDSX Discussion

Your Recent History

Company

Business

Popular

Get The App

Sign in

Go Ad-Free